2[3]Cutolo M, Sulli A, Pizzorni C, et al. Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis,2001, 60(8): 729-735.
3[4]Link AA, Kino T, Worth JA, et al. Ligand-activation of the adenosine A2α receptors inhibits IL-12 production by human monocytes. J Immunol, 2000, 164( 1 ): 436-442.
4[5]Montesinos MC, Yap JS, Desai A. Reversal of the antiinflammatory effects of methotrexate by nonselective adenosine receptor antagonists theophylline and caffeine. Arthritis Rheum, 2000, 43(3): 656-663.
5[6]Montesinos MC, Desai A, Delano D, et al. Adenosine A2α or A3receptors required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum, 2003, 48( 1 ): 240-247.
6[7]Majumdar S, Aggarwal BB. Methotrexate suppresses NF-kappaB activation through inhibition of I kappa B alpha phosphorylation and degradation. J Immunol, 2001, 167 (5): 2911-2920.
7[8]Cutolo M, Bisso A, Sulli A, et al. Antiprolfferative and anti-in-flammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from rheumatoid arthritis patients. J Rheumatol, 2000, 27(11): 2552-2557.
8[9]Genestier L, Paillot R, Foumel S, et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest, 1998, 120(2): 322-328.
9[10]de Lathouder S, Gerards AH, de Groot ER, et al. Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms. Eur Cytokine Netw, 2002, 13(3): 317-323.
10[11]Homung N, Stengaard PK, Ehrnrooth E, et al. The effects of lowdose methotrexate on thymidylate synthesis activity in human peripheral blood mononuclear cells. Clin Exp Rheumatol, 2000,18(6): 691-698.